A Post-Authorisation Safety Study (PASS) of ABRYSVO (Respiratory Syncytial Virus Stabilised Prefusion Subunit Vaccine) in Pregnant Women and their Offspring in a Real World Setting in Europe and UKFirst published 13/01/2025 Last updated 12/02/2025 EU PAS number: EUPAS1000000399StudyPlanned